Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

3(42.9%)

Phase 4

2(28.6%)

Phase 2

1(14.3%)

Phase 3

1(14.3%)

7Total

N/A(3)

Phase 4(2)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT02992262Not ApplicableUnknown

Ocular Point of Care Ultrasound (POCUS) to Detect Optic Disc Swelling in Comparison to Ophthalmologic Examination

Role: lead

NCT02963792Not ApplicableUnknown

Burnout Preventions, Professionalism Heightening, and Enhancing Resiliency (BUPHER)

Role: lead

NCT02825316Not ApplicableUnknown

Mediterranean Diet as an add-on Therapy for Induction of Remission in Patients With Active Crohn's Disease

Role: lead

NCT02443194Phase 3Terminated

The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients

Role: lead

NCT02354560Phase 4Unknown

Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-minors' Adjusted Version

Role: lead

NCT02175914Phase 4Unknown

Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis

Role: lead

NCT01898416Phase 2Recruiting

Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors

Role: lead

All 7 trials loaded